ClinicalTrialsFinder
RecruitingNCT04291651

UCSF PANC Cyst Registry

Population-Based Analysis of Neoplastic Changes in Cystic Lesions of the Pancreas.

Sponsor

University of California, San Francisco

Enrollment

4,000 participants

Start Date

Oct 8, 2019

Study Type

OBSERVATIONAL

Conditions

Pancreatic CancerPancreatic Ductal AdenocarcinomaPancreatic NeoplasmsPancreatic CystIntraductal Papillary Mucinous NeoplasmPancreatic DiseasesPancreatic Intraductal Papillary Mucinous NeoplasmMucinous Cyst

Summary

Pancreatic cysts are found incidentally on 15-50% of CT and MRIs for all indications and their prevalence is increasing. Many of these cysts may be precursors to pancreatic cancer, and thus pose a substantial risk, however, the vast majority are benign. Increased detection of pancreatic cysts provides an opportunity to diagnose pancreatic malignancy at an early, curable stage yet also increases the potential to over-treat clinically insignificant lesions. This presents a clinical challenge to prevent unnecessary resection of indolent disease, with associated risks of infections, bleeding, diabetes, and costly disability. Unfortunately, there is little information on the epidemiology and natural history of pancreatic cysts to help guide management.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This is a registry at UCSF that tracks patients with pancreatic cysts — fluid-filled sacs in the pancreas — over time. It collects health information and follow-up data to better understand which cysts are at risk of becoming cancerous and how best to manage them. **You may be eligible if...** - You are 30 years old or older - You have at least one pancreatic cyst identified by imaging or endoscopy - You do not have a history of pancreatic cancer - You can read and speak English - You have access to a computer or mobile device - You can complete an electronic consent form **You may NOT be eligible if...** - You have a prior diagnosis of pancreatic cancer - You cannot read English - You do not have access to a digital device Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERSurvey

There are no study-specific interventions, as this is a prospective registry. However, patients will be asked to complete approximately 1-2 hours worth of surveys on things such as demographics, medical and surgical history, and pancreatic cyst-specific questionnaires.

Locations(1)

University of California, San Francisco

San Francisco, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04291651

Related Trials

DESTINY-PANTUMOUR04

NCT0712400017 locations

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

NCT0621891418 locations

A Study Comparing BMS-986504 in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30)

NCT07076121279 locations

A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours

NCT0630524712 locations

Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)

NCT0725223217 locations